Lowell Satler, MD
Interventional Cardiology · Washington, DCNPI 1255381778
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Abbott at 45.9% of the total. Reporting peaked in 2019 at $50,178 and has fallen 94.6% since, to $2,710 in 2025.
Across 489 payments — averaging $229.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$51K
- AstraZeneca$17K
- Medtronic$15K
- Chiesi USA, Inc.$11K
- Boston Scientific$9K
- Edwards Lifesciences$2K
- plus $7K from 28 others
Across 385 payments — averaging $5653.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$1.5M
- Edwards Lifesciences$401K
- Medtronic$141K
- Livanova USA, Inc.$62K
- Abbott$32K
- Biotronik Inc.$15K
- plus $300 from 1 others
What the payments were for
- Consulting fees$42,24838%
- Speaking & faculty fees$42,70038%
- Travel & lodging$6,5876%
- Food & beverage$20,48218%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 95 | $51,478 |
| AstraZeneca | 52 | $16,753 |
| Medtronic(2 entities) | 91 | $15,480 |
| Chiesi USA, Inc. | 17 | $10,808 |
| Boston Scientific | 47 | $8,630 |
| Edwards Lifesciences | 25 | $1,731 |
| Ancora Heart, Inc. | 6 | $1,274 |
| Teleflex LLC | 11 | $975 |
| Amgen | 26 | $748 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $472 |
| Cardiovascular Systems Inc. | 9 | $448 |
| Abiomed | 6 | $319 |
| Jenavalve Technology, Inc. | 2 | $293 |
| E.r. Squibb & Sons, L.L.C. | 10 | $285 |
| Pfizer | 15 | $271 |
| Johnson & Johnson | 15 | $260 |
| Heartflow, Inc. | 1 | $203 |
| W. L. Gore & Associates, Inc. | 1 | $188 |
| Novartis | 7 | $184 |
| Novo Nordisk | 8 | $163 |
| Penumbra, Inc. | 1 | $150 |
| GE HealthCare | 1 | $143 |
| Philips North America LLC | 1 | $130 |
| Cardinal Health 200 LLC | 2 | $127 |
| Inari Medical, Inc. | 1 | $115 |
| Biotronik Inc. | 1 | $108 |
| Asahi Intecc USA, Inc. | 4 | $88 |
| Cardiva Medical, Inc. | 2 | $53 |
| Celonova Biosciences, Inc. | 1 | $49 |
| Boehringer Ingelheim | 2 | $41 |
| Shockwave Medical, Inc | 1 | $28 |
| Atricure, Inc. | 1 | $23 |
| Terumo Medical Corporation | 1 | $19 |
| Recor Medical Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER Occluders$36,364
- BRILINTA$14,526
- KENGREAL$10,368
- Watchman$6,235
- AMPLATZER TALISMAN$4,706
- AMPLATZER$3,347
- MitraClip$2,500
- Resolute$1,350
- AccuCinch$1,200
- COREVALVE EVOLUT R$1,154
- CoreValve Evolut$703
- SYMPLICITY G3$668
- Edwards SAPIEN 3 Transcatheter Heart Valve$609
- RESOLUTE ONYX$532
- MANTA$450
- WATCHMAN Access System$433
- Mitra Clip system$391
- ONYX FRONTIER$349
- COROFLOW$346
- DRAGONFLY OPSTAR$336
How this compares
Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $472 |
| Enoxaparin Sodium | 12 | $366 |
| Prednisone | 31 | $43 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Washington
- Ron WaksmanWashington$915K
- Toby RogersWashington$880K
- Augusto PichardWashington$180K
- Jonathan ReinerWashington$77K
- Brian CaseWashington$63K
- Horst SievertWashington$58K
- Nelson BernardoWashington$55K
- Ramesh MazhariWashington$41K
- Itshac Ben-DorWashington$25K
- Nardos TemesgenWashington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.